FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116716375> ?p ?o ?g. }

• W2116716375 endingPage "192" @default.
• W2116716375 startingPage "185" @default.
• W2116716375 abstract "The effect of hereditary alpha-1 antitrypsin (AAT) deficiency can manifest clinically in the form of chronic obstructive pulmonary disease (COPD). AAT deficiency (AATD) is defined as a serum concentration lower than 35% of the expected mean value or 50 mg/dl (determined by nephelometry). It is associated in over 95% of cases with Pi*ZZ genotypes, and much less frequently with other genotypes resulting from combinations of Z, S, rare and null alleles. A systematic qualitative review was made of 107 articles, focusing mainly on an active search for AATD in COPD patients and intravenous (iv) treatment with AAT. On the basis of this review, the consultant committee of the Spanish Registry of Patients with AATD recommends that all COPD patients be screened for AATD with the determination of AAT serum concentrations, and when these are low, the evaluation must be completed with phenotyping and, on occasions, genotyping. Patients with severe AATD COPD should receive the pharmacological and non-pharmacological treatment recommended in the COPD guidelines. There is enough evidence from large observational studies and randomized placebo-controlled clinical trials to show that the administration of iv AAT reduces mortality and slows the progression of emphysema, hence its indication in selected cases that meet the inclusion criteria stipulated in international guidelines. The administration of periodic infusions of AAT is the only specific treatment for delaying the progression of emphysema associated with AATD." @default.
• W2116716375 created "2016-06-24" @default.
• W2116716375 creator A5010824509 @default.
• W2116716375 creator A5030633450 @default.
• W2116716375 creator A5042246684 @default.
• W2116716375 creator A5043614888 @default.
• W2116716375 creator A5046413590 @default.
• W2116716375 creator A5050928126 @default.
• W2116716375 creator A5051893292 @default.
• W2116716375 creator A5057215097 @default.
• W2116716375 creator A5058669821 @default.
• W2116716375 creator A5062472986 @default.
• W2116716375 creator A5071831143 @default.
• W2116716375 creator A5091607729 @default.
• W2116716375 date "2015-04-01" @default.
• W2116716375 modified "2023-10-09" @default.
• W2116716375 title "Indications for Active Case Searches and Intravenous Alpha-1 Antitrypsin Treatment for Patients With Alpha-1 Antitrypsin Deficiency Chronic Pulmonary Obstructive Disease: An Update" @default.
• W2116716375 cites W1526753735 @default.
• W2116716375 cites W1587433306 @default.
• W2116716375 cites W168858771 @default.
• W2116716375 cites W1921725433 @default.
• W2116716375 cites W1962481619 @default.
• W2116716375 cites W1969116676 @default.
• W2116716375 cites W1969884127 @default.
• W2116716375 cites W1972903466 @default.
• W2116716375 cites W1977335577 @default.
• W2116716375 cites W1981271734 @default.
• W2116716375 cites W1984115516 @default.
• W2116716375 cites W1995832270 @default.
• W2116716375 cites W1996398325 @default.
• W2116716375 cites W1997414434 @default.
• W2116716375 cites W1997686025 @default.
• W2116716375 cites W1998442642 @default.
• W2116716375 cites W2001844754 @default.
• W2116716375 cites W2004406029 @default.
• W2116716375 cites W2017082953 @default.
• W2116716375 cites W2022553333 @default.
• W2116716375 cites W2024627002 @default.
• W2116716375 cites W2027212845 @default.
• W2116716375 cites W2027545901 @default.
• W2116716375 cites W2030201588 @default.
• W2116716375 cites W2033942625 @default.
• W2116716375 cites W2038851075 @default.
• W2116716375 cites W2041092358 @default.
• W2116716375 cites W2044177822 @default.
• W2116716375 cites W2059220887 @default.
• W2116716375 cites W2062281969 @default.
• W2116716375 cites W2066175645 @default.
• W2116716375 cites W2068606391 @default.
• W2116716375 cites W2075565532 @default.
• W2116716375 cites W2079065919 @default.
• W2116716375 cites W2081169091 @default.
• W2116716375 cites W2084027193 @default.
• W2116716375 cites W2087181420 @default.
• W2116716375 cites W2090004150 @default.
• W2116716375 cites W2090595042 @default.
• W2116716375 cites W2093732736 @default.
• W2116716375 cites W2093801914 @default.
• W2116716375 cites W2097516276 @default.
• W2116716375 cites W2097779875 @default.
• W2116716375 cites W2098777305 @default.
• W2116716375 cites W2099430328 @default.
• W2116716375 cites W2100624477 @default.
• W2116716375 cites W2104081530 @default.
• W2116716375 cites W2108071221 @default.
• W2116716375 cites W2108670155 @default.
• W2116716375 cites W2110246071 @default.
• W2116716375 cites W2110600773 @default.
• W2116716375 cites W2112665587 @default.
• W2116716375 cites W2115161783 @default.
• W2116716375 cites W2119128997 @default.
• W2116716375 cites W2119134270 @default.
• W2116716375 cites W2119784688 @default.
• W2116716375 cites W2122693539 @default.
• W2116716375 cites W2126501872 @default.
• W2116716375 cites W2127819544 @default.
• W2116716375 cites W2129208675 @default.
• W2116716375 cites W2130138851 @default.
• W2116716375 cites W2131065421 @default.
• W2116716375 cites W2131810149 @default.
• W2116716375 cites W2132122933 @default.
• W2116716375 cites W2134129764 @default.
• W2116716375 cites W2136588715 @default.
• W2116716375 cites W2138087639 @default.
• W2116716375 cites W2139207431 @default.
• W2116716375 cites W2139446077 @default.
• W2116716375 cites W2143492848 @default.
• W2116716375 cites W2144086043 @default.
• W2116716375 cites W2145648281 @default.
• W2116716375 cites W2148670040 @default.
• W2116716375 cites W2149043719 @default.
• W2116716375 cites W2149674883 @default.
• W2116716375 cites W2152958095 @default.
• W2116716375 cites W2160424004 @default.
• W2116716375 cites W2161807399 @default.
• W2116716375 cites W2163696530 @default.
• W2116716375 cites W2164176583 @default.
• W2116716375 cites W2169025633 @default.

• next